For the readers interested in the stock health of Predictive Oncology Inc. (POAI). It is currently valued at $1.23. When the transactions were called off in the previous session, Stock hit the highs of $1.24, after setting-off with the price of $1.1627. Company’s stock value dipped to $1.16 during the trading on the day. When the trading was stopped its value was $1.14.
Recently in News on June 22, 2021, Predictive Oncology Inc.’s Subsidiaries Soluble Biotech Inc. and TumorGenesis Inc. are both constructing new GMP labs. Predictive Oncology (NASDAQ: POAI), an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries, Soluble Biotech Inc. and TumorGenesis Inc. are both expanding their unique services by completing the fabrication and qualification of GMP facilities. You can read further details here
Predictive Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.3000 on 02/17/21, with the lowest value was $0.7100 for the same time period, recorded on 01/08/21.
Predictive Oncology Inc. (POAI) full year performance was -29.31%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Predictive Oncology Inc. shares are logging -46.52% during the 52-week period from high price, and 95.24% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.63 and $2.30.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3050502 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Predictive Oncology Inc. (POAI) recorded performance in the market was 67.94%, having the revenues showcasing 12.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 83.85M, as it employees total of 22 workers.
Market experts do have their say about Predictive Oncology Inc. (POAI)
During the last month, 0 analysts gave the Predictive Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2195, with a change in the price was noted -0.24. In a similar fashion, Predictive Oncology Inc. posted a movement of -16.33% for the period of last 100 days, recording 3,102,069 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for POAI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Predictive Oncology Inc. (POAI)
Raw Stochastic average of Predictive Oncology Inc. in the period of last 50 days is set at 51.76%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 57.50%. In the last 20 days, the company’s Stochastic %K was 47.25% and its Stochastic %D was recorded 46.86%.
Bearing in mind the latest performance of Predictive Oncology Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 67.94%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -0.81%, alongside a downfall of -29.31% for the period of the last 12 months. The shares increased approximately by 9.82% in the 7-day charts and went down by 20.59% in the period of the last 30 days. Common stock shares were driven by 12.84% during last recorded quarter.